R&CPMK to Drive Brand Development and Strategic Communications for Launch of Medibio’s Pioneering Consumer Mental Health App

Melbourne, Australia and Minneapolis, MN – July 29, 2021 – Leading health technology company Medibio Limited (ASX: MEB) (OTCPINK: MDBIF), today announced that it has selected R&CPMK, the preeminent integrated marketing and communications agency in global entertainment, media, and technology, to drive brand development and strategic communications for the upcoming launch of Medibio’s pioneering consumer mental health app in the United States.

Led by Managing Director Claude Solitario, and Chief Medical Officer Archie Defillo – alongside a Board of Directors which includes many of the world’s leading experts in healthcare and mental health advocacy – Medibio offers healthcare and mental well-being solutions for businesses and consumers through a suite of advanced technology programs.

“Medibio’s pioneering work in the use of biometric data to aid in the early detection and screening of mental health conditions underpins the vision of our new consumer app,” said Solitario. “We look forward to working with R&CPMK to help us bring our revolutionary consumer mental health app to market, and to advance the positive and necessary global conversation surrounding mental health and wellness.”

“Mental health is one of the most important issues facing society today, and millions of people around the world continue to suffer in silence due to the lack of awareness and unfortunate stigma surrounding mental illness,” said Cary Kwok, Executive Vice President, R&CPMK. “We are pleased to be working with Medibio to introduce their new app, and further educate consumers on this science-driven technology that will help countless people improve their mental well-being.”

In the United States, increased stress and anxiety during the COVID-19 pandemic has adversely impacted the mental health of an estimated 53% percent of adults, and 71% reported that they could have used more emotional support. Medibio aims to address the increased demand for online mental health services, through the development of its consumer app, which will be launched and available on Android and iOS platforms in October of 2021.

Designed to identify the link between biological markers and mental health conditions, Medibio’s technology empowers individuals to self-screen and better understand their own mental wellness. Medibio’s app and algorithms identify how stress is affecting individuals, and in turn produces stress assessment data to offer cognitive behavioral exercises, educational tools, and goal setting features to help users develop solutions that improve their mental health. To learn more about Medibio, click here.

To the read the full article from PRWEEK, click here.